{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:31:23Z","timestamp":1792690283144,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this study was to identify the predictors of relapse and severe disease in non-systemic juvenile idiopathic arthritis (JIA), a heterogeneous childhood disease. Patients with JIA were grouped based on relapse status, and those with\u2009\u2265\u20092 relapses requiring biologics were classified as severe disease phenotype. A total of 142 patients (63.4% female) were included in the study. Seventy-three patients (51.4%) experienced at least one relapse after achieving remission, who were significantly characterized by female gender, younger age at diagnosis, positive ANA test, and longer disease duration. Ankle, elbow, metacarpophalangeal (MCP), and temporomandibular joint (TMJ) involvement was more prevalent in patients who had experienced at least one relapse. Longer disease duration, higher number of joints involved at the time of diagnosis, and MCP involvement were found as independent risk factors for relapse. Twenty patients (14%) were grouped as having a severe disease phenotype, characterized by a younger age at the time of diagnosis, longer disease duration, and a higher number of joints involved throughout the disease course. Younger age at diagnosis, ankle involvement, and TMJ involvement were found to be independent risk factors for a severe disease phenotype.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : In our study, longer disease duration, MCP joint involvement, and a higher number of joints involved at the time of diagnosis were found to be associated with relapse in non-systemic JIA patients. On the other hand, younger age at diagnosis, ankle and TMJ involvement were associated with severe disease phenotype.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">What is Known:\u2022 JIA is a chronic joint disease characterized by relapses and remissions, and approximately half of patients experience at least one relapse after remission.<\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">What is New:\u2022 Multiple relapses and bDMARD requirement may define a severe disease course. Younger age, ankle, and TMJ involvement may predict severe disease course.\u2022 Relapses may occur with longer disease duration; not every relapse implies a severe disease course.<\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06842-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:39:00Z","timestamp":1774334340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-8948","authenticated-orcid":false,"given":"Do\u011facan","family":"Sar\u0131soy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0306-7473","authenticated-orcid":false,"given":"Fatma","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-8082","authenticated-orcid":false,"given":"\u00d6zen","family":"Ta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-6440","authenticated-orcid":false,"given":"Onur","family":"Bah\u00e7eci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0354-5300","authenticated-orcid":false,"given":"Bet\u00fcl","family":"\u00d6ks\u00fcz Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-8378","authenticated-orcid":false,"given":"Elif","family":"Erorhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-4491","authenticated-orcid":false,"given":"Tu\u011fba","family":"Akkaya Hocagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-9189","authenticated-orcid":false,"given":"Zeynep Birsin","family":"\u00d6z\u00e7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"2","key":"6842_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"2","key":"6842_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R et al (2019) Toward new classification criteria for juvenile \u0131diopathic arthritis: first steps, pediatric rheumatology \u0131nternational trials organization \u0131nternational consensus. J Rheumatol 46(2):190\u2013197","journal-title":"J Rheumatol"},{"issue":"4","key":"6842_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63(4):465\u2013482","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"6842_CR4","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1007\/s00431-023-05123-9","volume":"182","author":"MM Kaplan","year":"2023","unstructured":"Kaplan MM, Kurt T, Polat MC, Sezer M, Ekici Tekin Z, Celikel E et al (2023) Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication. Eur J Pediatr 182(10):4557\u20134564","journal-title":"Eur J Pediatr"},{"issue":"5","key":"6842_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/14397595.2020.1836788","volume":"31","author":"M Sezer","year":"2021","unstructured":"Sezer M, Aydin F, Kurt T, Tekgoz N, Tekin ZE, Karagol C et al (2021) Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis. Mod Rheumatol 31(5):1025\u20131030","journal-title":"Mod Rheumatol"},{"issue":"4","key":"6842_CR6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/art.10146","volume":"46","author":"B Flato","year":"2002","unstructured":"Flato B, Smerdel A, Johnston V, Lien G, Dale K, Vinje O et al (2002) The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum 46(4):986\u2013994","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6842_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Childhood Arthritis Rheumatology Research A et al (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63(7):929\u2013936","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"6842_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3899\/jrheum.170794","volume":"45","author":"A Aquilani","year":"2018","unstructured":"Aquilani A, Marafon DP, Marasco E, Nicolai R, Messia V, Perfetti F et al (2018) Predictors of flare following etanercept withdrawal in patients with rheumatoid factor-negative juvenile \u0131diopathic arthritis who reached remission while taking medication. J Rheumatol 45(7):956\u2013961","journal-title":"J Rheumatol"},{"issue":"10","key":"6842_CR9","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/art.30502","volume":"63","author":"K Baszis","year":"2011","unstructured":"Baszis K, Garbutt J, Toib D, Mao J, King A, White A et al (2011) Clinical outcomes after withdrawal of anti-tumor necrosis factor alpha therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum 63(10):3163\u20133168","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6842_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00296-014-3103-2","volume":"35","author":"C Gimenez-Roca","year":"2015","unstructured":"Gimenez-Roca C, Iglesias E, Torrente-Segarra V, Bou R, Sanchez-Manubens J, Calzada-Hernandez J et al (2015) Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age. Rheumatol Int 35(2):323\u2013326","journal-title":"Rheumatol Int"},{"issue":"1","key":"6842_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/annrheumdis-2018-213902","volume":"78","author":"P Hissink Muller","year":"2019","unstructured":"Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ et al (2019) Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial. Ann Rheum Dis 78(1):51\u201359","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6842_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13075-021-02492-0","volume":"23","author":"J Klotsche","year":"2021","unstructured":"Klotsche J, Klein A, Niewerth M, Hoff P, Windschall D, Foeldvari I et al (2021) Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis. Arthritis Res Ther 23(1):118","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"6842_CR13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/art.40509","volume":"70","author":"DJ Lovell","year":"2018","unstructured":"Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y et al (2018) Risk, timing, and predictors of disease flare after discontinuation of anti-tumor necrosis factor therapy in children with polyarticular forms of juvenile \u0131diopathic arthritis with clinically \u0131nactive disease. Arthritis Rheumatol 70(9):1508\u20131518","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"6842_CR14","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s10067-017-3682-x","volume":"36","author":"Y Su","year":"2017","unstructured":"Su Y, Yang YH, Chiang BL (2017) Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes. Clin Rheumatol 36(9):1997\u20132004","journal-title":"Clin Rheumatol"},{"issue":"6","key":"6842_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","volume":"75","author":"J Guzman","year":"2016","unstructured":"Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N et al (2016) The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis 75(6):1092\u20131098","journal-title":"Ann Rheum Dis"},{"key":"6842_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005369","author":"AK Tuomi","year":"2025","unstructured":"Tuomi AK, Rebane K, Arnstad E, Berntson L, Fasth A, Glerup M et al (2025) Age at diagnosis as a prognostic factor in selected categories of juvenile idiopathic arthritis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2024-005369","journal-title":"RMD Open"},{"issue":"10","key":"6842_CR17","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/rheumatology\/key148","volume":"57","author":"EHP van Dijkhuizen","year":"2018","unstructured":"van Dijkhuizen EHP, Aidonopoulos O, TerHaar NM, PiresMarafon D, Magni-Manzoni S, Ioannidis YE et al (2018) Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study. Rheumatology (Oxford) 57(10):1752\u20131760","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"6842_CR18","first-page":"719","volume":"20","author":"L Lepore","year":"2002","unstructured":"Lepore L, Del Santo M, Malorgio C, Presani G, Perticarari S, Prodan M et al (2002) Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T gamma\/delta + and B CD5+ lymphocyte populations of synovial fluid. Clin Exp Rheumatol 20(5):719\u2013722","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"6842_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/acr.23435","volume":"70","author":"G Simonini","year":"2018","unstructured":"Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A et al (2018) Flares after withdrawal of biologic therapies in juvenile \u0131diopathic arthritis: clinical and laboratory correlates of remission duration. Arthritis Care Res (Hoboken) 70(7):1046\u20131051","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"6842_CR20","first-page":"751","volume":"33","author":"AC Esbjornsson","year":"2015","unstructured":"Esbjornsson AC, Aalto K, Brostrom EW, Fasth A, Herlin T, Nielsen S et al (2015) Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 33(5):751\u2013757","journal-title":"Clin Exp Rheumatol"},{"key":"6842_CR21","doi-asserted-by":"publisher","unstructured":"Artamonov AK, Kaneva MA, Gordeeva NA, Sorokina LS, Kostik MM (2023) Temporomandibular joint \u0131nvolvement in juvenile \u0131diopathic arthritis: the results from a retrospective cohort tertial center study. Life (Basel) 13(5):1164. https:\/\/doi.org\/10.3390\/life13051164","DOI":"10.3390\/life13051164"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06842-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:54:41Z","timestamp":1776930881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6842"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06842-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}